BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2668931)

  • 1. Protein meal-stimulated pancreatic polypeptide secretion in Prader-Willi syndrome of adults.
    Tomita T; Greeley G; Watt L; Doull V; Chance R
    Pancreas; 1989; 4(4):395-400. PubMed ID: 2668931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome.
    Zipf WB; O'Dorisio TM; Cataland S; Dixon K
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1074-80. PubMed ID: 6352724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunted pancreatic polypeptide responses in children with obesity of Prader-Willi syndrome.
    Zipf WB; O'Dorisio TM; Cataland S; Sotos J
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1264-6. PubMed ID: 7014602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide YY, cholecystokinin, insulin and ghrelin response to meal did not change, but mean serum levels of insulin is reduced in children with Prader-Willi syndrome.
    Paik KH; Jin DK; Lee KH; Armstrong L; Lee JE; Oh YJ; Kim S; Kwon EK; Choe YH
    J Korean Med Sci; 2007 Jun; 22(3):436-41. PubMed ID: 17596650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cholecystokinin levels in Prader-Willi syndrome and obese subjects.
    Butler MG; Carlson MG; Schmidt DE; Feurer ID; Thompson T
    Am J Med Genet; 2000 Nov; 95(1):67-70. PubMed ID: 11074497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome.
    Bizzarri C; Rigamonti AE; Giannone G; Berardinelli R; Cella SG; Cappa M; Müller EE
    Horm Metab Res; 2004 Mar; 36(3):164-9. PubMed ID: 15057669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
    Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
    Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
    Goldstone AP; Holland AJ; Butler JV; Whittington JE
    Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
    Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term infusion of pancreatic polypeptide: effect on children with Prader-Willi syndrome.
    Zipf WB; O'Dorisio TM; Berntson GG
    Am J Clin Nutr; 1990 Feb; 51(2):162-6. PubMed ID: 2407095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed response of amylin levels after an oral glucose challenge in children with Prader-Willi syndrome.
    Lee HJ; Choe YH; Lee JH; Sohn YB; Kim SJ; Park SW; Son JS; Kim SW; Jin DK
    Yonsei Med J; 2011 Mar; 52(2):257-62. PubMed ID: 21319343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome.
    Kuppens RJ; Diène G; Bakker NE; Molinas C; Faye S; Nicolino M; Bernoux D; Delhanty PJ; van der Lely AJ; Allas S; Julien M; Delale T; Tauber M; Hokken-Koelega AC
    Endocrine; 2015 Dec; 50(3):633-42. PubMed ID: 25989955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects.
    Talebizadeh Z; Butler MG
    Clin Genet; 2005 Mar; 67(3):230-9. PubMed ID: 15691361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cholecystokinin and pancreatic polypeptide secretion in response to bombesin, meal ingestion and modified sham feeding in lean and obese persons.
    Lieverse RJ; Masclee AA; Jansen JB; Lamers CB
    Int J Obes Relat Metab Disord; 1994 Feb; 18(2):123-7. PubMed ID: 8148926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting and meal-induced CCK and PP secretion following intragastric balloon treatment for obesity.
    Mathus-Vliegen EM; de Groot GH
    Obes Surg; 2013 May; 23(5):622-33. PubMed ID: 23224567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial cardiac autonomic function in Prader-Willi syndrome.
    Purtell L; Jenkins A; Viardot A; Herzog H; Sainsbury A; Smith A; Loughnan G; Steinbeck K; Campbell LV; Sze L
    Clin Endocrinol (Oxf); 2013 Jul; 79(1):128-33. PubMed ID: 23106348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects.
    Kennedy L; Bittel DC; Kibiryeva N; Kalra SP; Torto R; Butler MG
    Int J Obes (Lond); 2006 Feb; 30(2):382-7. PubMed ID: 16231029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.
    Sze L; Purtell L; Jenkins A; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1314-9. PubMed ID: 21632815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome.
    Haqq AM; Farooqi IS; O'Rahilly S; Stadler DD; Rosenfeld RG; Pratt KL; LaFranchi SH; Purnell JQ
    J Clin Endocrinol Metab; 2003 Jan; 88(1):174-8. PubMed ID: 12519848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones.
    Haqq AM; Muehlbauer M; Svetkey LP; Newgard CB; Purnell JQ; Grambow SC; Freemark MS
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):944-51. PubMed ID: 17666087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.